サノフィ(Sanofi、Euronext: SAN NYSE: SNY)は、フランス・パリを本拠とする製薬・バイオテクノロジー企業である。医薬品(処方箋医薬品)販売では、世界第4位(2008年)となっている[8]。
Chris Viehbacher (born 1960) is a German-Canadian businessman.[1][2][3][4] He served as the Chief Executive Officer of Sanofi and Chairman of Genzyme until 29 October 2014.[2][3][4]
BiographyEarly lifeChris Viehbacher was born on March 26, 1960.[4] He graduated from Queen's University in Kingston, Ontario, Canada.[1][3][4] He is a certified public accountant, and he speaks French, German and English.[1][3][4]CareerHe started his career at PriceWaterhouseCoopers.[1][3][4] In 1988, he joined GlaxoSmithKline, where he worked for the next twenty years, including in France for ten years.[1][3] Until October 29 2014, he served as CEO of Sanofi and Chairman of Genzyme.[3][4]
毒腐湯蟹ラインの排除があからさまになってきましたね。(爆wwwwwwwwwwwwww
1 件のコメント:
仏ロ首脳会談開催
http://headlines.yahoo.co.jp/hl?a=20141206-00000118-jij-eurp
結果で色々読めますな、展開が
コメントを投稿